Glenda C Gobe Selected Research

caspase-activated DNase inhibitor

1/2016

Decreased Expression of Inhibitor of Caspase-Activated DNase (ICAD) in Renal Cell Carcinoma - Tissue Microarray of Human Samples.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glenda C Gobe Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 01/2005
19	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2005
18	Chronic Renal Insufficiency 09/2022 - 10/2011
13	Fibrosis (Cirrhosis) 01/2022 - 09/2002
12	Kidney Diseases (Kidney Disease) 09/2022 - 10/2010
11	Inflammation (Inflammations) 01/2022 - 02/2007
11	Kidney Neoplasms (Kidney Cancer) 06/2019 - 07/2007
9	Necrosis 09/2019 - 09/2002
6	Acute Kidney Injury (Acute Renal Failure) 07/2018 - 06/2012
5	Prostatic Neoplasms (Prostate Cancer) 05/2019 - 10/2009
4	Renal Insufficiency (Renal Failure) 09/2022 - 06/2012
4	Albuminuria 01/2022 - 01/2015
4	Body Weight (Weight, Body) 10/2021 - 07/2007
4	Chronic Kidney Failure (Chronic Renal Failure) 05/2019 - 12/2015
4	Neoplasm Metastasis (Metastasis) 05/2019 - 01/2016
4	Ischemia 01/2018 - 01/2007
3	Hypertension (High Blood Pressure) 08/2019 - 01/2017
3	Carcinogenesis 06/2019 - 10/2007
3	Hypoxia (Hypoxemia) 01/2019 - 05/2011
3	Atrophy 01/2018 - 02/2007
2	Diabetic Nephropathies (Diabetic Nephropathy) 09/2022 - 07/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2012
2	Thrombosis (Thrombus) 01/2021 - 05/2019
2	Breast Neoplasms (Breast Cancer) 10/2018 - 01/2017
2	Hypertrophy 01/2018 - 02/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 05/2012
2	Obesity 10/2017 - 01/2008
2	Carcinoma (Carcinomatosis) 01/2016 - 10/2007
2	Cardiomegaly (Heart Hypertrophy) 12/2014 - 02/2014
1	Pain (Aches) 10/2021
1	Ascites 10/2021
1	Fever (Fevers) 10/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Infections 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Diabetes Mellitus 01/2020
1	renal Oncocytoma 05/2019

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 05/2019 - 10/2007
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
6	AntioxidantsIBA 01/2022 - 05/2012
6	CadmiumIBA 01/2022 - 01/2017
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2012
6	CreatinineIBA 10/2017 - 06/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2008
4	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 02/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 09/2002
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 07/2007
4	Erythropoietin FDA Link 03/2014 - 05/2011
3	Sunitinib (Sutent)FDA Link 01/2022 - 04/2016
3	ChemokinesIBA 09/2019 - 01/2007
3	Caveolin 1IBA 05/2019 - 10/2009
3	CytokinesIBA 05/2019 - 01/2007
3	Estrogen ReceptorsIBA 10/2018 - 12/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 08/2003
3	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 07/2007
3	NitrogenIBA 01/2015 - 06/2012
3	Urea (Carbamide)FDA LinkGeneric 01/2015 - 06/2012
3	AndrogensIBA 05/2014 - 06/2010
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2007 - 09/2002
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	EnzymesIBA 10/2021 - 09/2012
2	CaspasesIBA 10/2021 - 01/2005
2	LigandsIBA 09/2019 - 02/2007
2	Fibronectins (Fibronectin)IBA 09/2019 - 02/2014
2	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 08/2019 - 10/2018
2	Glycoproteins (Glycoprotein)IBA 05/2019 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 10/2018 - 04/2016
2	Plant ExtractsIBA 01/2018 - 12/2015
2	Adenine FDA LinkGeneric 01/2018 - 12/2014
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2013
2	Small Interfering RNA (siRNA)IBA 04/2016 - 08/2012
2	Carvedilol (Coreg)FDA LinkGeneric 02/2016 - 10/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 02/2014
2	Androgen Receptors (Androgen Receptor)IBA 05/2014 - 10/2009
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2013 - 03/2013
2	TNF Receptor-Associated Factor 1IBA 08/2012 - 04/2009
1	tocilizumab (atlizumab)FDA Link 01/2022
1	QuercetinIBA 10/2021
1	CatalaseIBA 10/2021
1	GlycosidesIBA 10/2021
1	Superoxide DismutaseIBA 10/2021
1	lapacholIBA 10/2021
1	Proteinase-Activated ReceptorsIBA 01/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	FibrinIBA 01/2021
1	InterleukinsIBA 09/2019
1	PAR-2 ReceptorIBA 09/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2019
1	Heavy MetalsIBA 05/2019
1	Keratin-7 (Cytokeratin 7)IBA 05/2019
1	ParaffinIBA 05/2019

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2005
12	Nephrectomy 09/2022 - 02/2014
3	Drug Therapy (Chemotherapy) 01/2016 - 01/2005
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 11/2018
2	Transplantation 01/2018 - 11/2011
2	Radiotherapy 01/2016 - 07/2007
1	Traditional Medicine (Folk Remedies) 10/2021